Skip to content
Screener

Rapid Micro Biosystems RPID Q2 2026 earnings

Reported August 7, 2026 · Before market open

Revenue$8.1MBeat by $179.0K
EPS-$0.27Miss by $0.03
Revenue estimate$7.9M
EPS estimate-$0.24
“Our second quarter results reflect continued execution against the strategic and financial priorities we outlined at the beginning of the year. Total revenue increased 11%, recurring revenue grew 14% and consumables achieved quarterly records in both units and revenue. Importantly, we delivered record second-quarter total gross margin of 15%, marking a positive inflection that reflects meaningful progress against our margin expansion initiatives and supports our path to positive cash flow.”
Robert Spignesi

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$10.0M
EPS estimate-$0.19

Financials

Q2 2026

Income statement

See full
Revenue$8.1M+10.9%
Gross profit$1.2M+341%
Operating income-$12.3M-1.4%
Net income-$12.9M-9.0%
EPS (diluted)-$0.270.0%

Balance sheet

See full
Cash & equivalents$15.0M-19.6%
Total debt$23.5M+318%
Total equity$17.7M-67.5%
Total assets$58.5M-22.7%

Cash flow

See full
Operating cash flow-$12.7M-30.9%
Free cash flow-$12.5M-24.0%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$83.77M-26.0%
Enterprise value$92.33M-7.8%
P/S2.4×-1.4×

Profitability

See full
Operating margin-141.5%-9.3pp
Net margin-145.6%-0.1pp
FCF margin-114.8%-9.6pp

Returns & leverage

See full
Return on equity-141.6%-501pp
Debt / equity1.3×+1.2×
Current ratio2.5×-1.1×

Segments

By product

See full
Service$2.8M+12.5%

FAQ

When did Rapid Micro Biosystems report Q2 2026 earnings?
Rapid Micro Biosystems (RPID) reported Q2 2026 earnings on August 7, 2026 before market open.
What were Rapid Micro Biosystems's Q2 2026 revenue and EPS?
Rapid Micro Biosystems reported revenue of $8.1M and eps of $-0.27 for Q2 2026.
Did Rapid Micro Biosystems beat estimates in Q2 2026?
Revenue beat the consensus estimate of $7.9M by $179.0K. EPS missed the consensus estimate of $-0.24 by $0.03.
How did Rapid Micro Biosystems's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.9% from $7.3M a year earlier and eps grew 0.0% from $-0.27.
Where can I find Rapid Micro Biosystems's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001380106-26-000097) and the 10-Q periodic report (0001380106-26-000101) directly on SEC EDGAR. The filing index links above go to sec.gov.